Study of a Respiratory Syncytial Virus/human Metapneumovirus vaccine candidate

Trial Identifier: VBD00003
Sponsor: Sanofi Pasteur, a Sanofi Company
Start Date: November 2023
Primary Completion Date: March 2026
Study Completion Date: March 2026
Condition: Metapneumovirus immunisation; Healthy Volunteers; Respiratory Syncytial Virus Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
PUERTO RICO Guayama, PUERTO RICO, 000784
PUERTO RICO San Juan, PUERTO RICO, 00909
UNITED STATES, California Los Alamitos, California, UNITED STATES, 90720
UNITED STATES, California Los Angeles, California, UNITED STATES, 90057
UNITED STATES, California Rolling Hills Estates, California, UNITED STATES, 90274
UNITED STATES, Florida Miami, Florida, UNITED STATES, 33173
UNITED STATES, Illinois Oakbrook Terrace, Illinois, UNITED STATES, 60181
UNITED STATES, Iowa Sioux City, Iowa, UNITED STATES, 51106
UNITED STATES, Kentucky LEXINGTON, Kentucky, UNITED STATES, 40509
UNITED STATES, Missouri Kansas City, Missouri, UNITED STATES, 64114
UNITED STATES, Puerto Rico SAN JUAN, Puerto Rico, UNITED STATES, 00918
UNITED STATES, Tennessee Knoxville, Tennessee, UNITED STATES, 37919
UNITED STATES, Texas Tomball, Texas, UNITED STATES, 77375